Benztropine Mesylate
46 NDCs across 8 manufacturers|46 Generic,0 Brand
Benztropine Mesylate is used to treat drug-induced abnormalities and parkinson disease, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 31, 1984. In 2024, Medicare Part D spent $24 million on Benztropine Mesylate across 1.9 million claims for 249,000 beneficiaries.
Benztropine Mesylate is available as 46 NDCs from 8 manufacturers (46 generic, 0 brand), with NADAC prices from $0.06 to $0.09 per EA — a 40% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
46
46G / 0B
Manufacturers
8
competing in market
Price Spread
$0.06 – $0.09
per EA
7d Activity
avg -1.0% WoW · of 46 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Chartwell RX LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Anticholinergic class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
8 manufacturers producing BENZTROPINE MESYLATE(3 pricing outliers)
Frequently Asked Questions
What is Benztropine Mesylate used to treat?
Benztropine Mesylate is used to treat drug-induced abnormalities and parkinson disease, per the National Library of Medicine's MED-RT classification.
When did Benztropine Mesylate become available as a generic?
FDA approved the first generic Benztropine Mesylate (ANDA) on Jan 31, 1984.
How much does Medicare spend on Benztropine Mesylate?
In 2024, Medicare Part D spent $24 million on Benztropine Mesylate across 1.9 million claims for 249,000 beneficiaries.
How many Benztropine Mesylate products are on the market?
The Benztropine Mesylate drug market contains 46 NDCs from 8 manufacturers — 46 generic and 0 brand products.
What is the price range for Benztropine Mesylate?
NADAC reference prices for Benztropine Mesylate range from $0.0647 to $0.0906 per EA — a 40% difference between cheapest and most expensive.
Which manufacturers make Benztropine Mesylate?
8 manufacturers list Benztropine Mesylate in NADAC. Ranked by number of NDCs, the largest are Chartwell RX LLC (10), Leading Pharma, LLC (6), Endo USA Inc. (6), Sunrise Pharmaceutical Inc. (6), ScieGen Pharmaceuticals Inc. (6).
How has the price of Benztropine Mesylate changed recently?
Over the past 7 days, 0 Benztropine Mesylate NDCs rose and 92 fell, with a market-wide average change of -1.0%.